IP Library Granted Patent US 9,833,503
Granted Patent B2
US 9,833,503 · App. 14/380,004 · Granted Dec 5, 2017

Methods for displaying polypeptides and uses thereof

Inventors: John Mekalanos (Brighton, MA); Marek Basler (Prague, CZ)
Assignee: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
A61K39/107C07K14/21C07K14/28C12N15/1037C12N15/74C12N15/78A61K39/00A61K2039/64C07K2319/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,833,503
App. No.
14/380,004
Granted
Dec 5, 2017
Kind
B2
Abstract

Provided herein are methods and compositions for displaying a polypeptide on a tubular structure and uses of such displayed polypeptides in the production of antibodies or vaccines.

Claims (9)

1. An isolated tubular structure comprised of a plurality of molecules of a VipA polypeptide of SEQ ID NO: 1 and a plurality of molecules of a VipB polypeptide of SEQ ID NO: 3,

wherein the VipA polypeptide molecules assemble with the VipB polypeptide molecules to form the tubular structure,

wherein the VipA polypeptide or the VipB polypeptide further comprises a polypeptide of interest as a fusion polypeptide, and

wherein the tubular structure displays a plurality of molecules of said polypeptide of interest.

2. A method for making a vaccine, the method comprising: combining an isolated tubular structure of claim 1 with a pharmaceutically acceptable carrier.

3. The isolated tubular structure of claim 1 , wherein the displayed polypeptide has a conformation substantially similar to the folding pattern of the protein of interest when not displayed in this manner.

4. The isolated tubular structure of claim 1 , wherein the displayed polypeptide is more immunogenic than the protein of interest when not displayed in this manner.

5. The isolated tubular structure of claim 1 , wherein the plurality of molecules of the polypeptide of interest are displayed as a regular, repetitive structure.

6. The isolated tubular structure of claim 1 , wherein the polypeptide of interest comprises a viral protein, a bacterial protein, a fungal protein or a tumor protein.

Assignments (2)
CONFIRMATORY LICENSE Recorded Nov 17, 2014
From: HARVARD UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034258/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2014
From: BASLER, MAREK; MEKALANOS, JOHN J.
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 033917/0811 →
Continuity (2)
Provisional Application 61602913 · Feb 24, 2012
Related Publication 20150132334A1 · May 14, 2015